OTCMKTS:NIMU - Non-Invasive Monitoring Systems Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.08 0.00 (0.00 %) (As of 05/20/2019 04:00 PM ET)Previous Close$0.08Today's Range$0.08 - $0.0852-Week Range$0.0420 - $0.16Volume10,000 shsAverage Volume2,535 shsMarket Capitalization$6.32 millionP/E RatioN/ADividend YieldN/ABeta0.32 ProfileChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Non-Invasive Monitoring Systems, Inc., together with its subsidiaries, engages in the research, development, manufacture, and marketing of a line of motorized, non-invasive, whole body, and periodic acceleration platforms in the United States and internationally. It offers Exer-Rest line of acceleration therapeutic platforms, including the Exer-Rest AT3800 and the Exer-Rest AT4700 models, which are whole body periodic acceleration therapeutic devices to healthy individuals, as well as for physicians and their patients. The company was incorporated in 1980 and is headquartered in Miami, Florida. Receive NIMU News and Ratings via Email Sign-up to receive the latest news and ratings for NIMU and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:NIMU Previous Symbol CUSIPN/A CIK720762 Webwww.nims-inc.com Phone305-575-4207Debt Debt-to-Equity RatioN/A Current Ratio2.12 Quick Ratio2.12Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$10,000.00 Price / Sales632.08 Cash FlowN/A Price / Cash FlowN/A Book Value($0.05) per share Price / Book-1.60Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-440,000.00 Net MarginsN/A Return on EquityN/A Return on Assets-660.39%Miscellaneous EmployeesN/A Outstanding Shares79,010,000Market Cap$6.32 million Next Earnings Date6/13/2019 (Estimated) OptionableNot Optionable Non-Invasive Monitoring Systems (OTCMKTS:NIMU) Frequently Asked Questions What is Non-Invasive Monitoring Systems' stock symbol? Non-Invasive Monitoring Systems trades on the OTCMKTS under the ticker symbol "NIMU." How were Non-Invasive Monitoring Systems' earnings last quarter? Non-Invasive Monitoring Systems, Inc. (OTCMKTS:NIMU) released its quarterly earnings data on Thursday, June, 14th. The company reported $0.00 earnings per share (EPS) for the quarter. View Non-Invasive Monitoring Systems' Earnings History. When is Non-Invasive Monitoring Systems' next earnings date? Non-Invasive Monitoring Systems is scheduled to release their next quarterly earnings announcement on Thursday, June 13th 2019. View Earnings Estimates for Non-Invasive Monitoring Systems. Has Non-Invasive Monitoring Systems been receiving favorable news coverage? Media headlines about NIMU stock have been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Non-Invasive Monitoring Systems earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future. Who are some of Non-Invasive Monitoring Systems' key competitors? Some companies that are related to Non-Invasive Monitoring Systems include Precision Optics (PEYE), Digirad (DRAD), Fc Global Realty (FCRE), CHF Solutions (CHFS), ENDRA Life Sciences (NDRA), Aradigm (ARDM), Vaso (VASO), Nexeon Medsystems (NXNN), Escalon Medical (ESMC), Reshape Lifesciences (RSLS), Trimedyne (TMED), SpectraScience (SCIE), Guided Therapeutics (GTHP), Newcardio (NWCI) and Echo Therapeutics (ECTE). Who are Non-Invasive Monitoring Systems' key executives? Non-Invasive Monitoring Systems' management team includes the folowing people: Dr. Jane H. Hsiao M.B.A., Ph.D., MBA, Chairman & Interim CEO (Age 72)Mr. James J. Martin CPA, CPA, MBA, CFO & Treasurer (Age 52)Mr. Joshua B. Weingard, Sec. (Age 46) How do I buy shares of Non-Invasive Monitoring Systems? Shares of NIMU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Non-Invasive Monitoring Systems' stock price today? One share of NIMU stock can currently be purchased for approximately $0.08. How big of a company is Non-Invasive Monitoring Systems? Non-Invasive Monitoring Systems has a market capitalization of $6.32 million and generates $10,000.00 in revenue each year. What is Non-Invasive Monitoring Systems' official website? The official website for Non-Invasive Monitoring Systems is http://www.nims-inc.com. How can I contact Non-Invasive Monitoring Systems? Non-Invasive Monitoring Systems' mailing address is 4400 Biscayne Blvd. Suite 180, Miami FL, 33137. The company can be reached via phone at 305-575-4207 or via email at 0. MarketBeat Community Rating for Non-Invasive Monitoring Systems (OTCMKTS NIMU)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 37 (Vote Outperform)Underperform Votes: 43 (Vote Underperform)Total Votes: 80MarketBeat's community ratings are surveys of what our community members think about Non-Invasive Monitoring Systems and other stocks. Vote "Outperform" if you believe NIMU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NIMU will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: What are the Different Types of Leveraged Buyouts? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.